Crown Bioscience

Crown Bioscience is a leading global contract research organization (CRO) dedicated to accelerating drug discovery and development, with a specialized focus on oncology and immuno-oncology. Founded in 2006, the company partners with biotechnology and pharmaceutical firms to provide comprehensive research solutions across the entire drug development continuum, from initial discovery through translational research and clinical trial support. Its mission centers on advancing novel therapies for complex cancer-related diseases by delivering scientifically rigorous and highly specialized research capabilities. The company operates with an employee range of 1,000-5,000 individuals and maintains a significant global footprint with 6 locations worldwide, underscoring its extensive operational capacity and reach in serving the life sciences sector.

Leveraging cutting-edge technology and a deep understanding of disease biology, Crown Bioscience offers a robust suite of services designed to meet the evolving needs of its clients. This includes advanced preclinical models, translational technology platforms, and specialized assays that enable faster and more effective evaluation of potential drug candidates. The company's expertise spans various therapeutic areas, aiming to support the development of next-generation treatments. Meet Crown Bioscience's team to understand the depth of scientific talent driving these innovations and ensuring high-quality research outcomes for partners worldwide.

In the competitive landscape of drug development services, Crown Bioscience distinguishes itself through its commitment to scientific excellence and client collaboration. Its primary products and services revolve around contract research, drug discovery, and the development of oncology and immuno-oncology treatments. The company's revenue stands at $211.8M, reflecting its substantial market presence and the demand for itsView more...